Live feed18:31:00·19dPRReleasevia QuantisnowEnhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast CancerByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
